Novogen to announce potential treatment for Facioscapulohumeral Muscular Dystrophy?, page-5

" Correction of these Criteria in vitro provides a basis for high content screening of novel small molecule therapeutics, A large body of evidence indicates that the Isoflavone molecule Genistien, can permanently modify epigenetic marks in the Gnome"

Novogen have already stated that they do not have the funds to work in this area, they are going to concentrate on their oncology drugs, does anybody here really believe that they will just sit on this stuff for another five years or thereabouts before working on it again when they have the funds available? I personally don't think that will be the case somehow, some sort of collaboration will happen here and I believe that will happen sooner rather than later.